Krisja Vermeylen
Director/Board Member presso MORPHOSYS AG
Patrimonio netto: 217 728 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Krisja Vermeylen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
41
| Public Company | Biotechnology | 41 |
| Public Company | Pharmaceuticals: Major | 25 | |
University of Antwerp
16
| College/University | Other Consumer Services | 16 |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Diaverum AB
 Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden.
2
| Subsidiary | Medical/Nursing Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Krisja Vermeylen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BP PLC | Integrated Oil | Chairman Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chairman Chief Executive Officer | |
KBC Bank NV
 KBC Bank NV Financial ConglomeratesFinance KBC Bank NV (KBC Bank) is the wholly-owned banking subsidiary of KBC Groupe SA (BE: KBC) in Belgium, an integrated bank insurance group serving mainly retail customers, small and medium-sized enterprises and private banking clientele. Based in Brussels, the bank was established in 1998 when Kredietbank, CERA Bank and ABB insurance company merged to create the KBC Bank and Insurance Holding Company. In 2005 the KBC Bank and Insurance Holding Company merged with their parent company, Almanij, to create KBC Group NV. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman Director/Board Member | |
| University of Cambridge | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Undergraduate Degree Masters Business Admin | |
| KBC GROUPE NV | Regional Banks | Director/Board Member Director of Finance/CFO Director/Board Member | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Georgetown University | College/University | Masters Business Admin Undergraduate Degree | |
| University of Münster | College/University | Undergraduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Undergraduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The private company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Director/Board Member Chief Executive Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact |
Statistiche
Distribuzione geografica
| Stati Uniti | 18 |
| Germania | 12 |
| Danimarca | 11 |
| Regno Unito | 5 |
| Belgio | 5 |
Settori
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 8 |
| Consumer Non-Durables | 3 |
| Miscellaneous | 3 |
Posizioni
| Director/Board Member | 336 |
| Corporate Officer/Principal | 152 |
| Independent Dir/Board Member | 106 |
| Chairman | 95 |
| Chief Executive Officer | 58 |
Contatti più connessi
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Chris Buyse | 39 |
| George Golumbeski | 36 |
| Gerald Heinz Möller | 29 |
| Karin Eastham | 29 |
| Thomas Paul Koestler | 26 |
| Sylvie Grégoire | 25 |
| Helge Lund | 24 |
| Wendy Johnson | 23 |
| Lars Rebien Sørensen | 22 |
| Frank Morich | 21 |
| Kasim Kutay | 21 |
| Brian Daniels | 20 |
| Hannu Ragnvald Ryöppönen | 20 |
| Mary Szela | 19 |
- Borsa valori
- Insiders
- Krisja Vermeylen
- Connessioni Società
